KRAS and cancer: Moreover, our results showed that CCNE2 might interact with cancer driver genes (AKT1 and KRAS), TP53 (the most frequently mutated gene), and PTEN in breast cancer patients, suggesting CCNE2 might be associated with tumorigenesis and genome stability.